Clinical Trials Browser

Phase 2/3 × Everolimus × Gynecologic × Clear all

NCT03285802 2020-02-05

Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene Mutation

Phase 2/3 Completed

Uterine Neoplasms